{
  "study_id": "NCT00268398",
  "study_title": "FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial",
  "table_name": "Table 1",
  "table_title": "Baseline demographic and clinical characteristics of patients",
  "description": "Baseline demographic and clinical characteristics for patients randomized to either the FOLFOX4 arm or the FOLFOX7-FOLFIRI arm.",
  "footnotes": [
    "CEA, carcinoembryonic antigen."
  ],
  "groups": [
    {
      "name": "FOLFOX4",
      "n": 142,
      "type": "intervention"
    },
    {
      "name": "FOLFOX7-FOLFIRI",
      "n": 142,
      "type": "intervention"
    }
  ],
  "characteristics": [
    {
      "original_label": "Age Median (range)",
      "standardized_name": "Age",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "numeric_mean_range",
          "mean_value": 63.0,
          "range_min": 29.0,
          "range_max": 78.0,
          "raw_string": "63.0 (29-78)",
          "notes": "The table reports this value as Median (range).",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "numeric_mean_range",
          "mean_value": 60.5,
          "range_min": 32.0,
          "range_max": 75.0,
          "raw_string": "60.5 (32-75)",
          "notes": "The table reports this value as Median (range).",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Gender",
      "standardized_name": "Sex",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Gender"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Gender"
        }
      ]
    },
    {
      "original_label": "Male",
      "standardized_name": "Male",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 91.0,
          "percentage": 64.1,
          "raw_string": "91 (64.1)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 99.0,
          "percentage": 69.7,
          "raw_string": "99 (69.7)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Female",
      "standardized_name": "Female",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 51.0,
          "percentage": 35.9,
          "raw_string": "51 (35.9)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 43.0,
          "percentage": 30.3,
          "raw_string": "43 (30.3)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "WHO performance status",
      "standardized_name": "WHO Performance Status",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "WHO performance status"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "WHO performance status"
        }
      ]
    },
    {
      "original_label": "0",
      "standardized_name": "WHO Performance Status 0",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "WHO Performance Status",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 99.0,
          "percentage": 69.7,
          "raw_string": "99 (69.7)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 91.0,
          "percentage": 64.1,
          "raw_string": "91 (64.1)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "WHO Performance Status 1",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "WHO Performance Status",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 33.0,
          "percentage": 23.3,
          "raw_string": "33 (23.3)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 41.0,
          "percentage": 28.9,
          "raw_string": "41 (28.9)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "2",
      "standardized_name": "WHO Performance Status 2",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "WHO Performance Status",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 4.0,
          "percentage": 2.8,
          "raw_string": "4 (2.8)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 5.0,
          "percentage": 3.5,
          "raw_string": "5 (3.5)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Not available",
      "standardized_name": "WHO Performance Status Not Available",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "WHO Performance Status",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 6.0,
          "percentage": 4.2,
          "raw_string": "6 (4.2)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 5.0,
          "percentage": 3.5,
          "raw_string": "5 (3.5)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Primary",
      "standardized_name": "Primary Tumor Location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Primary"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Primary"
        }
      ]
    },
    {
      "original_label": "Colon",
      "standardized_name": "Colon",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary Tumor Location",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 101.0,
          "percentage": 71.1,
          "raw_string": "101 (71.1)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 94.0,
          "percentage": 66.2,
          "raw_string": "94 (66.2)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Rectum",
      "standardized_name": "Rectum",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary Tumor Location",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 41.0,
          "percentage": 28.9,
          "raw_string": "41 (28.9)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 48.0,
          "percentage": 33.8,
          "raw_string": "48 (33.8)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Primary previously resected Yes",
      "standardized_name": "Primary Tumor Previously Resected",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 73.0,
          "percentage": 51.4,
          "raw_string": "73 (51.4)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 74.0,
          "percentage": 52.1,
          "raw_string": "74 (52.1)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Primary nodal status",
      "standardized_name": "Primary Nodal Status",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Primary nodal status"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Primary nodal status"
        }
      ]
    },
    {
      "original_label": "N0",
      "standardized_name": "N0",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary Nodal Status",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 58.0,
          "percentage": 40.8,
          "raw_string": "58 (40.8)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 60.0,
          "percentage": 42.2,
          "raw_string": "60 (42.2)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "N+",
      "standardized_name": "N+",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary Nodal Status",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 82.0,
          "percentage": 57.7,
          "raw_string": "82 (57.7)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 81.0,
          "percentage": 57.0,
          "raw_string": "81 (57.0)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Unknown",
      "standardized_name": "Primary Nodal Status Unknown",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary Nodal Status",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 1.4,
          "raw_string": "2 (1.4)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.7,
          "raw_string": "1 (0.7)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Prior adjuvant therapy",
      "standardized_name": "Prior Adjuvant Therapy",
      "category": "Treatment History",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Prior adjuvant therapy"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Prior adjuvant therapy"
        }
      ]
    },
    {
      "original_label": "Yes",
      "standardized_name": "Prior Adjuvant Therapy Yes",
      "category": "Treatment History",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Prior Adjuvant Therapy",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 32.0,
          "percentage": 22.5,
          "raw_string": "32 (22.5)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 39.0,
          "percentage": 27.5,
          "raw_string": "39 (27.5)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "No",
      "standardized_name": "Prior Adjuvant Therapy No",
      "category": "Treatment History",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Prior Adjuvant Therapy",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 110.0,
          "percentage": 77.5,
          "raw_string": "110 (77.5)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 103.0,
          "percentage": 72.5,
          "raw_string": "103 (72.5)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Time from primary to metastases",
      "standardized_name": "Time from Primary Tumor to Metastases",
      "unit": "months",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Time from primary to metastases"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Time from primary to metastases"
        }
      ]
    },
    {
      "original_label": ">12 months",
      "standardized_name": "Time from Primary Tumor to Metastases >12 months",
      "unit": "months",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Time from Primary Tumor to Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 40.0,
          "percentage": 28.2,
          "raw_string": "40 (28.2)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 51.0,
          "percentage": 35.9,
          "raw_string": "51 (35.9)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "<12 months",
      "standardized_name": "Time from Primary Tumor to Metastases <12 months",
      "unit": "months",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Time from Primary Tumor to Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 101.0,
          "percentage": 71.1,
          "raw_string": "101 (71.1)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 90.0,
          "percentage": 63.4,
          "raw_string": "90 (63.4)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Not available",
      "standardized_name": "Time from Primary Tumor to Metastases Not Available",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Time from Primary Tumor to Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.7,
          "raw_string": "1 (0.7)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.7,
          "raw_string": "1 (0.7)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Total number of metastases",
      "standardized_name": "Number of Metastases",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Total number of metastases"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Total number of metastases"
        }
      ]
    },
    {
      "original_label": "0",
      "standardized_name": "Number of Metastases 0",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "raw_string": "0 (-)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.7,
          "raw_string": "1 (0.7)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "Number of Metastases 1",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 70.0,
          "percentage": 49.3,
          "raw_string": "70 (49.3)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 69.0,
          "percentage": 48.6,
          "raw_string": "69 (48.6)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "2",
      "standardized_name": "Number of Metastases 2",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 38.0,
          "percentage": 26.8,
          "raw_string": "38 (26.8)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 36.0,
          "percentage": 25.3,
          "raw_string": "36 (25.3)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "3",
      "standardized_name": "Number of Metastases 3",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 21.0,
          "percentage": 14.8,
          "raw_string": "21 (14.8)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 19.0,
          "percentage": 13.4,
          "raw_string": "19 (13.4)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "4",
      "standardized_name": "Number of Metastases 4",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 7.0,
          "percentage": 4.9,
          "raw_string": "7 (4.9)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 11.0,
          "percentage": 7.7,
          "raw_string": "11 (7.7)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "≥5",
      "standardized_name": "Number of Metastases ≥5",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 6.0,
          "percentage": 4.2,
          "raw_string": "6 (4.2)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 6.0,
          "percentage": 4.2,
          "raw_string": "6 (4.2)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Maximal metastases diameter",
      "standardized_name": "Maximal Metastases Diameter",
      "unit": "cm",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Maximal metastases diameter"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Maximal metastases diameter"
        }
      ]
    },
    {
      "original_label": "<5 cm",
      "standardized_name": "Maximal Metastases Diameter <5 cm",
      "unit": "cm",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Maximal Metastases Diameter",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 121.0,
          "percentage": 85.2,
          "raw_string": "121 (85.2)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 118.0,
          "percentage": 83.1,
          "raw_string": "118 (83.1)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": ">5 cm",
      "standardized_name": "Maximal Metastases Diameter >5 cm",
      "unit": "cm",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Maximal Metastases Diameter",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 20.0,
          "percentage": 14.1,
          "raw_string": "20 (14.1)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 22.0,
          "percentage": 15.5,
          "raw_string": "22 (15.5)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Not available",
      "standardized_name": "Maximal Metastases Diameter Not Available",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Maximal Metastases Diameter",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.7,
          "raw_string": "1 (0.7)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 1.4,
          "raw_string": "2 (1.4)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Number of metastatic sites",
      "standardized_name": "Number of Metastatic Sites",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Number of metastatic sites"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Number of metastatic sites"
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "Number of Metastatic Sites 1",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Metastatic Sites",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 132.0,
          "percentage": 93.0,
          "raw_string": "132 (93.0)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 138.0,
          "percentage": 97.2,
          "raw_string": "138 (97.2)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "2",
      "standardized_name": "Number of Metastatic Sites 2",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Metastatic Sites",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 9.0,
          "percentage": 6.3,
          "raw_string": "9 (6.3)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 4.0,
          "percentage": 2.8,
          "raw_string": "4 (2.8)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "3",
      "standardized_name": "Number of Metastatic Sites 3",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Metastatic Sites",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.7,
          "raw_string": "1 (0.7)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "raw_string": "0 (-)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Sites of metastases",
      "standardized_name": "Sites of Metastases",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Sites of metastases"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Sites of metastases"
        }
      ]
    },
    {
      "original_label": "Liver",
      "standardized_name": "Liver",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sites of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 118.0,
          "percentage": 83.1,
          "raw_string": "118 (83.1)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 118.0,
          "percentage": 83.1,
          "raw_string": "118 (83.1)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Lung",
      "standardized_name": "Lung",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sites of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 20.0,
          "percentage": 14.1,
          "raw_string": "20 (14.1)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 20.0,
          "percentage": 14.1,
          "raw_string": "20 (14.1)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Peritoneum",
      "standardized_name": "Peritoneum",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sites of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 11.0,
          "percentage": 7.7,
          "raw_string": "11 (7.7)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 6.0,
          "percentage": 4.2,
          "raw_string": "6 (4.2)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Node",
      "standardized_name": "Node",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sites of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.7,
          "raw_string": "1 (0.7)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.7,
          "raw_string": "1 (0.7)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Ovary",
      "standardized_name": "Ovary",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sites of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 3.0,
          "percentage": 2.1,
          "raw_string": "3 (2.1)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "raw_string": "0 (-)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Other site",
      "standardized_name": "Other Metastatic Site",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sites of Metastases",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "raw_string": "0 (-)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.7,
          "raw_string": "1 (0.7)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Fong score",
      "standardized_name": "Fong Prognostic Score",
      "category": "Prognostic Scores",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Fong score"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Fong score"
        }
      ]
    },
    {
      "original_label": "0-1",
      "standardized_name": "Fong Prognostic Score 0-1",
      "category": "Prognostic Scores",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Fong Prognostic Score",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 43.0,
          "percentage": 30.3,
          "raw_string": "43 (30.3)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 50.0,
          "percentage": 35.2,
          "raw_string": "50 (35.2)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "2-3",
      "standardized_name": "Fong Prognostic Score 2-3",
      "category": "Prognostic Scores",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Fong Prognostic Score",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 90.0,
          "percentage": 63.4,
          "raw_string": "90 (63.4)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 82.0,
          "percentage": 57.7,
          "raw_string": "82 (57.7)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "4-5",
      "standardized_name": "Fong Prognostic Score 4-5",
      "category": "Prognostic Scores",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Fong Prognostic Score",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 9.0,
          "percentage": 6.3,
          "raw_string": "9 (6.3)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 10.0,
          "percentage": 7.0,
          "raw_string": "10 (7.0)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Serum CEA level",
      "standardized_name": "Serum Carcinoembryonic Antigen Level",
      "unit": "ng/ml",
      "category": "Biomarkers",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Serum CEA level"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Serum CEA level"
        }
      ]
    },
    {
      "original_label": "<200 ng/ml",
      "standardized_name": "Serum Carcinoembryonic Antigen Level <200 ng/ml",
      "unit": "ng/ml",
      "category": "Biomarkers",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Serum Carcinoembryonic Antigen Level",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 131.0,
          "percentage": 92.2,
          "raw_string": "131 (92.2)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 134.0,
          "percentage": 94.4,
          "raw_string": "134 (94.4)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "≥200 ng/ml",
      "standardized_name": "Serum Carcinoembryonic Antigen Level ≥200 ng/ml",
      "unit": "ng/ml",
      "category": "Biomarkers",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Serum Carcinoembryonic Antigen Level",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 9.0,
          "percentage": 6.3,
          "raw_string": "9 (6.3)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 6.0,
          "percentage": 4.2,
          "raw_string": "6 (4.2)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Not available",
      "standardized_name": "Serum Carcinoembryonic Antigen Level Not Available",
      "category": "Biomarkers",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Serum Carcinoembryonic Antigen Level",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 1.4,
          "raw_string": "2 (1.4)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 1.4,
          "raw_string": "2 (1.4)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Treatment strategy",
      "standardized_name": "Treatment Strategy",
      "category": "Treatment Plan",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "header",
          "raw_string": "Treatment strategy"
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "header",
          "raw_string": "Treatment strategy"
        }
      ]
    },
    {
      "original_label": "Resected population (postoperative chemotherapy)",
      "standardized_name": "Resected population (postoperative chemotherapy)",
      "category": "Treatment Plan",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Treatment Strategy",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 57.0,
          "percentage": 40.1,
          "raw_string": "57 (40.1)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 59.0,
          "percentage": 41.5,
          "raw_string": "59 (41.5)",
          "n_for_value": 142
        }
      ]
    },
    {
      "original_label": "Resectable population (perioperative chemotherapy)",
      "standardized_name": "Resectable population (perioperative chemotherapy)",
      "category": "Treatment Plan",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Treatment Strategy",
      "group_data": [
        {
          "group_name": "FOLFOX4",
          "data_type": "categorical_count_percentage",
          "count": 85.0,
          "percentage": 59.8,
          "raw_string": "85 (59.8)",
          "n_for_value": 142
        },
        {
          "group_name": "FOLFOX7-FOLFIRI",
          "data_type": "categorical_count_percentage",
          "count": 83.0,
          "percentage": 58.4,
          "raw_string": "83 (58.4)",
          "n_for_value": 142
        }
      ]
    }
  ]
}